Conference Insight

Agnostic or pure players in the biotech sector: Who is getting prominent in the early-stage financing rounds?
Read more...
Conference Insight

What is the right balance between equity, royalties, collaborative research income for the academic institutions in the process of spinning out companies?
Read more...

Subscribe to our monthly newsletter